Dimethyl fumarate D6 is the hexa-deuterated form (in the terminal methyl groups) of Dimethyl fumarate (DMF, Tecfidera; Skilarence), which is an immunomodulator and Nrf2 activator that has been approved by the U.S. FDA for the treatment of relapsing multiple sclerosis and by the European Medicines Agency (EMA) for managing moderate-to-severe plaque psoriasis.

纯度：≥98%

CAS：66487-95-4